The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Martina Haberecker, Rebekka Wegmann et al.|Cancer Cell|2021Cited by 140
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Berend Snijder, Rebekka Wegmann et al.|Nature Medicine|2024Cited by 68
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivšek, Berend Snijder, Rebekka Wegmann et al.|Nature Cancer|2023Cited by 42
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Stefanie Engler, Faisal Alquaddoomi et al.|Nature Communications|2024Cited by 25
The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Mitchell P. Levesque, Gunnar Rätsch et al.|medRxiv|2020Cited by 20